BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38391311)

  • 81. Machine learning-based CT texture analysis to predict HPV status in oropharyngeal squamous cell carcinoma: comparison of 2D and 3D segmentation.
    Ren J; Yuan Y; Qi M; Tao X
    Eur Radiol; 2020 Dec; 30(12):6858-6866. PubMed ID: 32591885
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States.
    Aggarwal H; Punekar RS; Li L; Carter GC; Walker MS
    Health Qual Life Outcomes; 2020 Jun; 18(1):195. PubMed ID: 32571349
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Preliminary Computed Tomography Radiomics Model for Predicting Pretreatment CD8+ T-Cell Infiltration Status for Primary Head and Neck Squamous Cell Carcinoma.
    Wang CY; Ginat DT
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):629-636. PubMed ID: 34519454
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.
    Kann BH; Hicks DF; Payabvash S; Mahajan A; Du J; Gupta V; Park HS; Yu JB; Yarbrough WG; Burtness BA; Husain ZA; Aneja S
    J Clin Oncol; 2020 Apr; 38(12):1304-1311. PubMed ID: 31815574
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dual-Layer Spectral CT Imaging of Upper Aerodigestive Tract Cancer: Analysis of Spectral Imaging Parameters and Impact on Tumor Staging.
    Hsu CC; Jeavon C; Fomin I; Du L; Buchan C; Watkins TW; Nae Y; Parry NM; Aviv RI
    AJNR Am J Neuroradiol; 2021 Sep; 42(9):1683-1689. PubMed ID: 34326102
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.
    Fu X; Chen S; Chen W; Yang Z; Song M; Li H; Zhang H; Yao F; Su X; Liu T; Yang AK
    Oral Oncol; 2018 Sep; 84():20-24. PubMed ID: 30115471
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Radiomics from Various Tumour Volume Sizes for Prognosis Prediction of Head and Neck Squamous Cell Carcinoma: A Voted Ensemble Machine Learning Approach.
    Tang FH; Cheung EY; Wong HL; Yuen CM; Yu MH; Ho PC
    Life (Basel); 2022 Sep; 12(9):. PubMed ID: 36143416
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
    Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
    Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
    EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Subjective and perceptive assessment of speech/voice and swallowing function before and after radiation therapy in patients of head-and-neck squamous cell cancer.
    Aggarwal VV; Waghmare CM; Lolage SN; Pawar HJ; Ravichandran M; Bhanu A
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147961
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma.
    Pan Z; Men K; Liang B; Song Z; Wu R; Dai J
    Radiother Oncol; 2023 Jul; 184():109684. PubMed ID: 37120101
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck.
    Chai RL; Rath TJ; Johnson JT; Ferris RL; Kubicek GJ; Duvvuri U; Branstetter BF
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1187-94. PubMed ID: 24076619
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
    Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
    Abdel Razek AAK; Nada N
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
    Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
    Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [
    Vos JL; Zuur CL; Smit LA; de Boer JP; Al-Mamgani A; van den Brekel MWM; Haanen JBAG; Vogel WV
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2010-2022. PubMed ID: 34957526
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study.
    Zhu Y; Meng Z; Wu H; Fan X; Lv W; Tian J; Wang K; Nie F
    Ultraschall Med; 2024 Jun; 45(3):305-315. PubMed ID: 38052240
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Radiogenomics is Elevating Treatment Response Prediction in Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Lu Y
    Acad Radiol; 2024 Jun; 31(6):2476-2477. PubMed ID: 38575419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.